Search results
Syros Pharmaceuticals, Inc. (SYRS) Moves to Strong Buy: Rationale Behind the Upgrade
Zacks via Yahoo Finance· 2 years agoSyros Pharmaceuticals, Inc. (SYRS) might move higher on growing optimism about its earnings...
Syros Pharmaceuticals, Inc. (SYRS) Reports Q3 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 years agoSyros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of 38.36% and 21.65%,...
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q1 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoSyros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q1 2023 Earnings Call Transcript May 10, 2023 Syros...
Strength Seen in Syros Pharmaceuticals, Inc. (SYRS): Can Its 5.4% Jump Turn into More Strength?
Zacks via Yahoo Finance· 1 year agoSyros Pharmaceuticals, Inc. (SYRS) saw its shares surge in the last session with trading volume...
Analysts Estimate Syros Pharmaceuticals, Inc. (SYRS) to Report a Decline in Earnings: What to Look...
Zacks via Yahoo Finance· 1 month agoSyros Pharmaceuticals (SYRS) doesn't possess the right combination of the two key ingredients for a...
individual investors who own 35% along with institutions invested in Syros Pharmaceuticals, Inc....
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights Syros Pharmaceuticals' significant individual investors ownership suggests that the key...
One Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) insider upped their stake by 212% in the previous year
Simply Wall St. via Yahoo Finance· 1 year agoViewing insider transactions for Syros Pharmaceuticals, Inc.'s (NASDAQ:SYRS ) over the last year, we...
Syros Pharmaceuticals, Inc. (SYRS) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks via Yahoo Finance· 5 months agoSyros Pharmaceuticals, Inc. (SYRS) could be a great choice for investors looking to make a profit...
Are You Looking for a Top Momentum Pick? Why Syros Pharmaceuticals, Inc. (SYRS) is a Great Choice
Zacks via Yahoo Finance· 5 months agoMomentum investing revolves around the idea of following a stock's recent trend in either direction....
Q1 2024 Syros Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 month agoParticipants Karen Hunady; IR; Syros Pharmaceuticals Inc Conley Chee; President, Chief Executive Officer, Director; Syros Pharmaceuticals Inc David Roth; Chief Medical Officer; Syros Pharmaceuticals ...